Orbimed Advisors as of Sept. 30, 2016
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 136 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 4.8 | $418M | 1.3M | 313.03 | |
| Boston Scientific Corporation (BSX) | 4.7 | $410M | 17M | 23.80 | |
| Amgen (AMGN) | 4.6 | $407M | 2.4M | 166.81 | |
| Alexion Pharmaceuticals | 3.7 | $323M | 2.6M | 122.54 | |
| Celgene Corporation | 3.5 | $308M | 2.9M | 104.53 | |
| Abbvie (ABBV) | 3.0 | $267M | 4.2M | 63.07 | |
| Merck & Co (MRK) | 2.7 | $241M | 3.9M | 62.41 | |
| Shire | 2.4 | $206M | 1.1M | 193.86 | |
| Allergan | 2.2 | $191M | 829k | 230.31 | |
| Intercept Pharmaceuticals In | 2.1 | $184M | 1.1M | 164.59 | |
| Eli Lilly & Co. (LLY) | 2.1 | $184M | 2.3M | 80.26 | |
| Wright Medical Group Nv | 2.1 | $180M | 7.4M | 24.53 | |
| Incyte Corporation (INCY) | 2.0 | $175M | 1.9M | 94.29 | |
| Agilent Technologies Inc C ommon (A) | 2.0 | $175M | 3.7M | 47.09 | |
| Edwards Lifesciences (EW) | 1.9 | $166M | 1.4M | 120.56 | |
| Puma Biotechnology (PBYI) | 1.8 | $160M | 2.4M | 67.05 | |
| Gilead Sciences (GILD) | 1.8 | $159M | 2.0M | 79.12 | |
| Ironwood Pharmaceuticals (IRWD) | 1.8 | $158M | 9.9M | 15.88 | |
| Molina Healthcare (MOH) | 1.8 | $154M | 2.6M | 58.32 | |
| WellCare Health Plans | 1.7 | $146M | 1.2M | 117.09 | |
| Regeneron Pharmaceuticals (REGN) | 1.6 | $143M | 355k | 402.02 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $141M | 1.6M | 87.21 | |
| Intuitive Surgical (ISRG) | 1.6 | $136M | 188k | 724.83 | |
| Thermo Fisher Scientific (TMO) | 1.5 | $130M | 817k | 159.06 | |
| Bristol Myers Squibb (BMY) | 1.4 | $123M | 2.3M | 53.92 | |
| Pfizer (PFE) | 1.4 | $120M | 3.5M | 33.87 | |
| BioMarin Pharmaceutical (BMRN) | 1.2 | $107M | 1.2M | 92.52 | |
| Achillion Pharmaceuticals | 1.2 | $106M | 13M | 8.10 | |
| Express Scripts Holding | 1.2 | $102M | 1.5M | 70.53 | |
| Johnson & Johnson (JNJ) | 1.1 | $101M | 858k | 118.13 | |
| Hca Holdings (HCA) | 1.1 | $99M | 1.3M | 75.63 | |
| Array BioPharma | 1.1 | $96M | 14M | 6.75 | |
| Zimmer Holdings (ZBH) | 1.1 | $93M | 718k | 130.02 | |
| Neurocrine Biosciences (NBIX) | 1.1 | $92M | 1.8M | 50.64 | |
| Illumina (ILMN) | 1.0 | $90M | 496k | 181.66 | |
| Impax Laboratories | 1.0 | $90M | 3.8M | 23.70 | |
| Corvus Pharmaceuticals (CRVS) | 1.0 | $89M | 5.4M | 16.45 | |
| UnitedHealth (UNH) | 1.0 | $86M | 612k | 140.00 | |
| Audentes Therapeutics | 1.0 | $86M | 4.8M | 17.81 | |
| Teva Pharmaceutical Industries (TEVA) | 1.0 | $84M | 1.8M | 46.01 | |
| Glaukos (GKOS) | 0.9 | $82M | 2.2M | 37.74 | |
| Mallinckrodt Pub | 0.9 | $82M | 1.2M | 69.78 | |
| Bluebird Bio (BLUE) | 0.9 | $80M | 1.2M | 67.78 | |
| Exelixis (EXEL) | 0.9 | $79M | 6.2M | 12.79 | |
| Insmed (INSM) | 0.9 | $76M | 5.3M | 14.52 | |
| Humana (HUM) | 0.8 | $75M | 424k | 176.89 | |
| Eagle Pharmaceuticals (EGRX) | 0.8 | $73M | 1.0M | 70.00 | |
| Allergan Plc pfd conv ser a | 0.8 | $73M | 88k | 821.49 | |
| Medtronic (MDT) | 0.8 | $66M | 767k | 86.40 | |
| Insys Therapeutics | 0.7 | $65M | 5.5M | 11.79 | |
| Ophthotech | 0.6 | $54M | 1.2M | 46.13 | |
| Loxo Oncology | 0.5 | $45M | 1.7M | 26.18 | |
| Intellia Therapeutics (NTLA) | 0.5 | $45M | 2.7M | 17.02 | |
| Cooper Companies | 0.5 | $45M | 250k | 179.26 | |
| Tenet Healthcare Corporation (THC) | 0.5 | $45M | 2.0M | 22.66 | |
| Ascendis Pharma A S (ASND) | 0.5 | $44M | 2.2M | 20.10 | |
| Dimension Therapeutics | 0.5 | $43M | 5.4M | 7.99 | |
| CIGNA Corporation | 0.5 | $42M | 326k | 130.32 | |
| Viewray (VRAYQ) | 0.5 | $41M | 9.1M | 4.52 | |
| Magellan Health Services | 0.4 | $38M | 700k | 53.73 | |
| Synergy Pharmaceuticals | 0.4 | $33M | 6.0M | 5.51 | |
| Otonomy | 0.4 | $34M | 1.9M | 18.19 | |
| Jazz Pharmaceuticals (JAZZ) | 0.3 | $30M | 247k | 121.48 | |
| Aerie Pharmaceuticals | 0.3 | $30M | 797k | 37.74 | |
| Galapagos Nv- (GLPG) | 0.3 | $30M | 458k | 64.66 | |
| Newlink Genetics Corporation | 0.3 | $29M | 1.9M | 15.02 | |
| Lion Biotechnologies | 0.3 | $28M | 3.4M | 8.23 | |
| Selecta Biosciences (RNAC) | 0.3 | $26M | 1.8M | 14.25 | |
| Immunomedics Inc note 4.750% 2/1 | 0.3 | $26M | 30M | 0.85 | |
| Stryker Corporation (SYK) | 0.3 | $25M | 212k | 116.41 | |
| eHealth (EHTH) | 0.2 | $20M | 1.8M | 11.21 | |
| EXACT Sciences Corporation (EXAS) | 0.2 | $21M | 1.1M | 18.57 | |
| Cynapsus Therapeutics | 0.2 | $20M | 500k | 40.23 | |
| Abbott Laboratories (ABT) | 0.2 | $19M | 441k | 42.29 | |
| Xencor (XNCR) | 0.2 | $18M | 745k | 24.49 | |
| Coherus Biosciences (CHRS) | 0.2 | $18M | 672k | 26.78 | |
| Inotek Pharmaceuticals | 0.2 | $18M | 1.8M | 9.48 | |
| ImmunoGen | 0.2 | $16M | 6.1M | 2.68 | |
| Forward Pharma A/s | 0.2 | $17M | 798k | 20.99 | |
| Sinovac Biotech (SVA) | 0.2 | $16M | 2.7M | 5.90 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $16M | 262k | 61.41 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.2 | $15M | 2.3M | 6.67 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $16M | 2.2M | 7.35 | |
| D Fluidigm Corp Del (LAB) | 0.2 | $14M | 1.7M | 8.01 | |
| Dermira | 0.2 | $14M | 426k | 33.82 | |
| Natera (NTRA) | 0.2 | $14M | 1.3M | 11.11 | |
| C.R. Bard | 0.1 | $13M | 58k | 224.28 | |
| Aetna | 0.1 | $14M | 117k | 115.45 | |
| Pieris Pharmaceuticals (PIRS) | 0.1 | $13M | 7.3M | 1.83 | |
| Vanda Pharmaceuticals (VNDA) | 0.1 | $13M | 750k | 16.64 | |
| Immunomedics | 0.1 | $12M | 3.8M | 3.25 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $12M | 169k | 70.94 | |
| Dbv Technologies S A (DBVT) | 0.1 | $13M | 346k | 36.33 | |
| Steadymed | 0.1 | $11M | 3.1M | 3.59 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $12M | 757k | 15.16 | |
| Sage Therapeutics (SAGE) | 0.1 | $11M | 235k | 46.05 | |
| Assembly Biosciences | 0.1 | $10M | 1.4M | 7.21 | |
| Affimed Therapeutics B V | 0.1 | $9.4M | 3.4M | 2.78 | |
| Nabriva Therapeutics | 0.1 | $9.3M | 1.3M | 7.05 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $9.5M | 7.0M | 1.36 | |
| Portola Pharmaceuticals | 0.1 | $8.4M | 371k | 22.71 | |
| Cellectis S A (CLLS) | 0.1 | $8.4M | 350k | 24.08 | |
| Aeglea Biotherapeutics | 0.1 | $8.7M | 1.4M | 6.41 | |
| NuVasive | 0.1 | $8.2M | 124k | 66.66 | |
| Redhill Biopharma Ltd cmn | 0.1 | $7.8M | 565k | 13.89 | |
| Minerva Neurosciences | 0.1 | $7.9M | 556k | 14.12 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $8.1M | 1.0M | 8.10 | |
| Sientra | 0.1 | $8.2M | 918k | 8.99 | |
| Incyte Corp. note 1.250 11/1 | 0.1 | $8.3M | 4.3M | 1.95 | |
| Incyte Corp note 0.375%11/1 | 0.1 | $8.1M | 4.3M | 1.90 | |
| Fluidigm Corporation convertible cor | 0.1 | $6.2M | 10M | 0.62 | |
| Infinity Pharmaceuticals (INFIQ) | 0.1 | $5.1M | 3.3M | 1.56 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $5.1M | 724k | 7.05 | |
| Valeant Pharmaceuticals Int | 0.1 | $4.8M | 195k | 24.55 | |
| Gw Pharmaceuticals Plc ads | 0.1 | $4.8M | 36k | 132.73 | |
| Invitae (NVTAQ) | 0.1 | $4.0M | 457k | 8.76 | |
| Amedisys (AMED) | 0.0 | $3.4M | 72k | 47.44 | |
| Sangamo Biosciences (SGMO) | 0.0 | $3.8M | 832k | 4.63 | |
| Uniqure Nv (QURE) | 0.0 | $3.7M | 489k | 7.65 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $3.5M | 12M | 0.29 | |
| Roka Bioscience | 0.0 | $2.2M | 3.2M | 0.69 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $1.4M | 90k | 15.26 | |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.0 | $1.5M | 5.2M | 0.28 | |
| Cogentix Medical | 0.0 | $1.6M | 878k | 1.82 | |
| Qlt | 0.0 | $1.0M | 500k | 2.06 | |
| Amarin Corporation (AMRN) | 0.0 | $1.1M | 350k | 3.19 | |
| Pernix Therapeutics Holdings | 0.0 | $665k | 1.1M | 0.62 | |
| Biolinerx Ltd-spons | 0.0 | $1.2M | 1.0M | 1.15 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $600k | 500k | 1.20 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $625k | 500k | 1.25 | |
| Marinus Pharmaceuticals | 0.0 | $1.0M | 568k | 1.82 | |
| Nivalis Therapeutics | 0.0 | $480k | 59k | 8.14 | |
| Xtant Med Holdings | 0.0 | $537k | 475k | 1.13 | |
| Medigus | 0.0 | $756k | 600k | 1.26 | |
| Alimera Sciences | 0.0 | $373k | 250k | 1.49 | |
| Aralez Pharmaceuticals | 0.0 | $330k | 68k | 4.84 |
